HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vincent Richard Selected Research

Non-Receptor Type 1 Protein Tyrosine Phosphatase

1/2019Gene Expression of Protein Tyrosine Phosphatase 1B and Endoplasmic Reticulum Stress During Septic Shock.
10/2018Protein tyrosine phosphatase 1B regulates endothelial endoplasmic reticulum stress; role in endothelial dysfunction.
1/2018Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
1/2017Reduced Insulin Resistance Contributes to the Beneficial Effect of Protein Tyrosine Phosphatase-1B Deletion in a Mouse Model of Sepsis.
12/2016Role of protein tyrosine phosphatase 1B in cardiovascular diseases.
5/2014Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
6/2012Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.
3/2009[New pharmacological approaches in heart failure: should we treat the endothelium?].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vincent Richard Research Topics

Disease

24Heart Failure
11/2021 - 08/2002
15Inflammation (Inflammations)
01/2021 - 06/2004
12Ischemia
12/2021 - 08/2002
12Myocardial Infarction
01/2018 - 11/2008
10Malaria
12/2015 - 03/2013
9Fibrosis (Cirrhosis)
07/2020 - 08/2011
8Left Ventricular Dysfunction
01/2021 - 10/2003
6Hypertrophy
04/2022 - 10/2003
6Cardiomegaly (Heart Hypertrophy)
04/2022 - 06/2011
6Infections
07/2020 - 07/2010
6Sepsis (Septicemia)
01/2020 - 05/2014
6Cardiovascular Diseases (Cardiovascular Disease)
03/2019 - 11/2007
5Breast Neoplasms (Breast Cancer)
03/2022 - 03/2007
5Hypertension (High Blood Pressure)
11/2021 - 06/2011
5Shock
10/2020 - 11/2006
5Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2019 - 11/2007
5Insulin Resistance
01/2017 - 06/2012
5Tuberculosis (Tuberculoses)
10/2015 - 07/2010
4Hypoxia (Hypoxemia)
11/2021 - 05/2006
4COVID-19
07/2020 - 06/2020
4Septic Shock (Toxic Shock Syndrome)
01/2019 - 08/2003
4Neoplasms (Cancer)
01/2019 - 01/2013
3Mitochondrial Diseases (Mitochondrial Disease)
04/2022 - 04/2016
3Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2020 - 08/2011
3Infarction (Infarctions)
01/2020 - 05/2007
3Ventricular Remodeling
01/2018 - 08/2017
3Hemorrhagic Shock
05/2009 - 08/2002
2Pulmonary Hypertension
11/2021 - 07/2014
2Weight Gain
01/2021 - 05/2015
2Reperfusion Injury
10/2019 - 10/2002
2Renal Cell Carcinoma (Grawitz Tumor)
06/2019 - 01/2019
2Body Weight (Weight, Body)
08/2018 - 09/2005
2Carcinogenesis
11/2015 - 08/2014

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2011
8Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
01/2019 - 03/2009
7Proteins (Proteins, Gene)FDA Link
06/2021 - 11/2008
7Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2018 - 08/2002
6Epoxide HydrolasesIBA
01/2020 - 06/2011
5Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 10/2003
54- (4- (3- adamantan- 1- ylureido)cyclohexyloxy)benzoic acidIBA
12/2021 - 05/2015
5AcidsIBA
03/2021 - 06/2011
5EnzymesIBA
01/2021 - 09/2008
5Glucose (Dextrose)FDA LinkGeneric
01/2021 - 05/2015
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013 - 08/2002
5Cocaine (Cocaine HCl)IBA
02/2007 - 10/2003
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 03/2012
4Antiphospholipid AntibodiesIBA
01/2019 - 06/2008
4CollagenIBA
10/2018 - 09/2008
4Lactic Acid (Lactate)FDA LinkGeneric
07/2017 - 08/2002
4artemisinin (artemisinine)IBA
05/2015 - 03/2013
3superoxide dismutase 2IBA
04/2022 - 11/2017
3DesminIBA
06/2021 - 07/2016
3Mineralocorticoid Receptor AntagonistsIBA
01/2021 - 09/2008
3Insulin (Novolin)FDA Link
01/2021 - 06/2012
3finerenoneIBA
01/2021 - 04/2016
3CytokinesIBA
10/2020 - 08/2003
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2020 - 08/2002
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2019 - 01/2018
3MicroRNAs (MicroRNA)IBA
03/2019 - 11/2017
3AntibodiesIBA
01/2018 - 05/2015
3Anti-Bacterial Agents (Antibiotics)IBA
01/2017 - 02/2014
3LipopolysaccharidesIBA
04/2016 - 08/2013
3Tuberculin (PPD)IBA
10/2015 - 07/2012
3AntioxidantsIBA
07/2015 - 10/2003
3Amodiaquine (Camoquin)FDA Link
05/2015 - 03/2013
3InsecticidesIBA
05/2015 - 01/2015
3Endothelins (Endothelin)IBA
07/2014 - 08/2002
3AldosteroneIBA
06/2011 - 11/2007
3Acetylcholine (Acetylcholine Chloride)FDA Link
06/2011 - 10/2002
3salicylhydroxamic acid (SHAM)IBA
12/2007 - 08/2002
2EverolimusFDA Link
03/2022 - 09/2021
2Phenobarbital (Luminal)FDA Link
03/2022 - 09/2021
2Drinking WaterIBA
12/2021 - 06/2011
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 11/2006
2Angiotensin-Converting Enzyme 2IBA
07/2020 - 06/2020
2Angiotensin II Type 1 Receptor BlockersIBA
07/2020 - 06/2020
2Pharmaceutical PreparationsIBA
06/2020 - 01/2017
2Natriuretic PeptidesIBA
10/2019 - 01/2018
2Tyrosine Kinase InhibitorsIBA
06/2019 - 01/2019
2Sunitinib (Sutent)FDA Link
06/2019 - 01/2019
2Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
10/2018 - 04/2016
2Messenger RNA (mRNA)IBA
01/2018 - 07/2015
2Therapeutic UsesIBA
01/2017 - 05/2014
2Macrophage Migration-Inhibitory FactorsIBA
11/2015 - 08/2014
2Troponin T (Troponin T1)IBA
07/2015 - 01/2011
2Immunoglobulin G (IgG)IBA
05/2015 - 01/2014
2Complex MixturesIBA
05/2015 - 03/2014
2ArtesunateIBA
05/2015 - 06/2014
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
04/2015 - 08/2011
2NitritesIBA
02/2015 - 10/2012
2Toll-Like Receptors (Toll-Like Receptor)IBA
11/2014 - 05/2009
2Protein Tyrosine PhosphatasesIBA
08/2014 - 12/2006
2Chloroquine (Aralen)FDA LinkGeneric
06/2014 - 03/2013
2Quinine (Quinson)FDA Link
06/2014 - 03/2013

Therapy/Procedure

14Therapeutics
04/2022 - 08/2002
6Ligation
01/2020 - 11/2008
3Punctures
01/2020 - 05/2014
3Resuscitation
05/2009 - 08/2002
2Chemoprevention
01/2015 - 03/2011
2Cardiopulmonary Bypass (Heart-Lung Bypass)
01/2013 - 06/2004